IMGN853-0401

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors


Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111
215-728-4300

Dana-Farber Cancer Institute
Boston, MA 02115
617-632-2949

Massachusetts General Hospital
Charlestown, MA 02129
617-724-8772

Ohio State University Comprehensive Cancer Center
410 West Tenth Avenue
Columbus, OH 43210
614-293-2598

Barbara Ann Karmanos Cancer Institute
3990 John R
Detroit, MI 48201
313-576-8716

University of Kansas Cancer Center
3901 Rainbow Boulevard
Kansas City, KS 66160
913-945-7420

University of Texas Health Science Center at San Antonio
7703 Floyd Curl Drive
San Antonio, TX 78229
210-450-3800